| 2023/06/02 22:00:01 | |
|---|---|
| Price | |
| 471.02 USD | |
| Difference | 1.42% (6.59) |
General attributes
| ISIN | US0367521038 |
| Symbol | ELV |
| Exchange | NYSE |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 103,769 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 462.65 USD (100) |
| Ask (Ask size) | 480.01 USD (100) |
| Open | 467.74 USD |
| High | 473.31 USD |
| Low | 462.32 USD |
| Close (prev. day) | 464.43 USD |
| VWAP | 470.604239 USD |
| Volume (pcs) | 1,618,169 |
| Trading volume | 758,643,164.28 |
| Number of trades | 23,747 |
| Last size | 194,957 |
Futures and Options
| Related Futures | 15 |
| Related Options | - |
PDF Downloads
| Company report: ELEVANCE HEALTH INC. |  |
Add Benchmark:
Recent research
| Date | Headline | Download | |
| 2023/06/01 |
|
Global Equity Ratings |
|
| 2023/05/24 |
|
Global Equity Ratings |
|
| 2023/05/03 |
|
Global Equity Ratings |
|
| 2023/04/25 |
|
Global Equity Ratings |
|
| 2023/03/28 |
|
Global Equity Ratings |
|
| 2023/06/02 22:00:01 | |
|---|---|
| Price | |
| 471.02 USD | |
| Difference | 1.42% (6.59) |
General attributes
| ISIN | US0367521038 |
| Symbol | ELV |
| Exchange | NYSE |
| Currency | USD |
| Sector | Chemical / Pharmaceutical / Health |
| Security type | Stock |
| Market cap (m) | 103,769 EUR |
| Benchmark | S&P 500 |
Market data
| Bid (Bid size) | 462.65 USD (100) |
| Ask (Ask size) | 480.01 USD (100) |
| Open | 467.74 USD |
| High | 473.31 USD |
| Low | 462.32 USD |
| Close (prev. day) | 464.43 USD |
| VWAP | 470.604239 USD |
| Volume (pcs) | 1,618,169 |
| Trading volume | 758,643,164.28 |
| Number of trades | 23,747 |
| Last size | 194,957 |
Performance and Risk
| 6m | 1Y | 3Y | |
| Perf (%) | -10.04% | -5.21% | +60.10% |
| Perf (abs.) | -52.58 | -25.91 | +176.82 |
| Beta | 0.50 | 0.50 | 0.66 |
| Volatility | 24.36 | 26.90 | 28.23 |
Add Benchmark:
Price data
| Ø price 5 days | Ø volume 5 days (pcs.) | 454.18 USD (1,707,639) |
| Ø price 30 days | Ø volume 30 days (pcs.) | 458.04 USD (1,056,370) |
| Ø price 100 days | Ø volume 100 days (pcs.) | 470.88 USD (1,110,703) |
| Ø price 250 days | Ø volume 250 days (pcs.) | 482.59 USD (1,055,547) |
| YTD High | date | 511.97 USD (2023/01/03) |
| YTD Low | date | 438.56 USD (2023/05/30) |
| 52 Weeks High | date | 549.52 USD (2022/10/31) |
| 52 Weeks Low | date | 438.56 USD (2023/05/30) |
All listings for ELEVANCE HEALTH INC.
| Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
| Xetra | 2023/05/31 | 17:35 | 418.00 EUR | 0.10 | 14 |
| Vienna Stock Exchange | 2023/06/02 | 17:32 | 440.00 EUR | 0.00 | 1 |
| Tradegate | 2023/06/02 | 22:26 | 440.00 EUR | 0.01 | 2 |
| Stuttgart | 2023/06/02 | 21:57 | 440.00 EUR | 0.00 | 5 |
| NYSE | 2023/06/02 | 22:00 | 471.02 USD | 758.64 | 23,747 |
| Munich | 2023/06/02 | 08:00 | 428.00 EUR | 0.00 | 1 |
| London Stock Exchange | 2023/05/30 | 16:25 | 440.51 USD | 6.07 | 2 |
| Frankfurt | 2023/06/02 | 16:48 | 434.00 EUR | 0.00 | 4 |
| Duesseldorf | 2023/06/02 | 21:01 | 438.00 EUR | 0.00 | 11 |
| Berlin | 2023/06/02 | 08:08 | 430.00 EUR | 0.00 | 1 |
| BX Swiss | 2023/04/17 | 15:05 | 469.791 CHF | 0.00 | 1 |
Company Logo
Contact Details
| ELEVANCE HEALTH INC. |
| - - |
| 220 Virginia Avenue - 46204 Indianapolis |
| Telefon: +1-800-331-1476 |
| Fax: + |
| E-mail: - |
PDF Downloads
| Company report: ELEVANCE HEALTH INC. | |
Company Profile
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Commercial and Specialty Business, Government Business, CarelonRx, and Other. The Commercial and Specialty Business segment provides insurance products and services such as stop loss, dental, vision, life, disability and supplemental health insurance. The Government Business segment includes medicare and medicaid businesses, national government services, and services provided to the federal government. The CerelonRx segment offers formulary management, pharmacy networks, prescription drug database, member services, and mail order capabilities. The Other segment is involved in health services business focused on quality of healthcare by enabling and creating new care delivery and payment models. The company was founded in 1944 and is headquartered in Indianapolis, IN. |
Members of Management Board
| Elizabeth Tallett | Chairman of Board of Directors |
| Bahija Jallal | Member of Board of Directors |
| Ryan Schneider | Member of Board of Directors |
| Antonio Neri | Member of Board of Directors |
| Deanna Strable-Soethout | Member of Board of Directors |
| Lewis Hay | Member of Board of Directors |
| R. Clark | Member of Board of Directors |
| Ramiro Peru | Member of Board of Directors |
| Robert Dixon | Member of Board of Directors |
| Susan DeVore | Member of Board of Directors |
| Gail Boudreaux | Chairman of Managing Board |
| Blair Todt | Member of Executive Committee |
| Felicia F. Norwood | Member of Executive Committee |
| Gloria McCarthy | Member of Executive Committee |
| John Gallina | Member of Executive Committee |
| Morgan Kendrick | Member of Executive Committee |
| Peter D. Haytaian | Member of Executive Committee |